Dr Michelle Spanevello is committed to delivering thorough, evidence-based clinical care. She prides herself on effective communication and believes in a team approach to tailoring personalised treatment plans for her patients and their loved ones.
Dr Michelle Spanevello is an experienced clinical haematologist at Icon Cancer Centre Chermside. In 2003, Dr Spanevello completed her Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Queensland and subsequently commenced specialist clinical and laboratory haematology training in Queensland. After obtaining her specialist qualifications, she worked as a clinical haematology staff specialist at the Royal Brisbane and Women’s Hospital (RBWH) and haematopathologist at QML Pathology. In 2016, Dr Spanevello completed an observership under Prof Terry Gernsheimer at the University of Washington Medical Center/Seattle Cancer Care Alliance to further her interest in non-malignant haematology.
With a passion for providing education and mentorship to the next generation of medical professionals, Dr Spanevello maintains an active role in the supervision of trainees, leads an educational non-malignant haematology program and is a senior lecturer at the University of Queensland’s School of Medicine. Alongside her practice at Icon, Dr Spanevello is a senior clinical haematology staff specialist and non-malignant haematology lead at the RBWH, chair of the RBWH Blood Management Committee and deputy chair of the Metro North Hospital and Health Services Blood Management Committee. She is a fellow of both the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australasia (FRCPA).
Dr Spanevello follows an integrated approach to patient management and actively participates in multidisciplinary team meetings to elevate the level of care for haematology patients. Her clinical experience covers a wide range of malignant and non-malignant blood disorders including multiple myeloma, leukaemia, lymphoma, myelodysplasia, immune cytopenias, myeloproliferative neoplasms, thrombosis and haemostasis.